« Return to News | CROs/Service Providers | Drug Sponsors

Pfizer talking with CROs to fill R&D hub

Wednesday, March 16, 2011 12:33 PM

A U.K. task force—assembled to salvage as many R&D jobs at Sandwich as it can before Pfizer completes its planned exit—has confirmed that the pharma giant is in discussions with CROs that may step in to hire some of the 2,400 workers being let go, according to Fierce Biotech.

Pfizer hopes the CROs will keep the research hub in operation, studying drugs for the pharma giant as well as others. The task force will be rooting for a slate of tax and planning breaks for companies moving into the research hub, which the group would like to turn into an economic enterprise zone.  Pfizer has also signed confidentiality agreements with 10 companies that have signaled an interest in picking up where Pfizer leaves off.

"Our report focuses on the opportunities presented by the world-class skills and facilities built by Pfizer over the last 60 years," said one of the task force leaders. "Combined, they offer a unique asset on which to build a new model of high-tech growth and employment, which would be of importance not only to Kent, but to the country."

Pfizer has made it clear that it plans to use more CRO talent to shoulder development work. It's been following in the footsteps of Eli Lilly, Sanofi-aventis, GlaxoSmithKline and others that have turned facilities over to CROs as they downsize in-house research operations.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.